Happy to recognize this stock a long time ago, and got on board over 2 years ago.
$220 million on the balance sheet Growing revenue across international markets, in a large market segment. Competitive advantage Strong IP, Money well spent on R & D Strong Management Stable Board
Looking forward to seeing this stock pay it's first dividend in the next few years. All stars ticked, this could be potentially a Cochlear for Heart Disease.
Absolute star performer!
HIN Price at posting:
$2.80 Sentiment: LT Buy Disclosure: Held
